The main active ingredient in Sinphar Memoregain® Capsules is Cistanche tubulosa extract, derived from a precious parasitic desert plant. This raw material has been studied and developed by Sinphar Pharmaceutical Group in Taiwan for more than 20 years, with related achievements earning dozens of patents in multiple countries. Using Phytomics QC™ fingerprinting quality control technology, the active component AIE2 was identified. This ingredient has been commercialized in more than 10 countries and has received dozens of patents worldwide. Its development is supported by research ranging from cell studies to human clinical trials, including Phase IV human clinical studies. Through scientific methods, this traditional medicinal herb has been developed for new health benefits, opening a new era in the revolution of postponing aging.
The factory has established comprehensive quality assurance standards and complies with international requirements. It has obtained multiple international certifications, including ISO 9001 Quality Management System, ISO 22000 Food Safety Management System, Good Hygiene Practice (GHP), and Good Manufacturing Practice (GMP) for health and nutrition foods. These certifications demonstrate that the factory meets internationally recognized quality management standards and is equipped with high-standard facilities and professional manufacturing expertise to ensure the supply of high-quality and safe products. In addition, the factory has obtained official BPJPH Halal Certification from Indonesia, ensuring that the production process complies with Halal requirements. This further aligns product quality with international Halal standards and supports expansion into diverse markets.
Cistanche tubulosa Extract (containing Cistanche Phenylethanoid Glycosides), Potato Starch, Magnesium Stearate
Capsule Shell: Gelatin, Titanium Dioxide, Sodium Lauryl Sulfate, FD&C Blue No. 1, FD&C Yellow No. 4, FD&C Yellow No. 5
Cistanche Phenylethanoid Glycosides: 80–120 mg per capsule
Sinphar Pharmaceutical Co., Ltd.
Our company has established independent Quality Control and Quality Inspection departments, with comprehensive supervision and tracking systems for relevant quality reports.
For raw material quality control, suppliers are required to undergo qualification review, including evaluation of relevant SOPs for management and audit procedures.
Quality control procedures are also established for semi-finished and finished products, including procedures such as food abnormality handling, to ensure proper management.
Testing of active ingredients related to health benefit claims
Safety and hygiene test reports, including microbiological and heavy metal testing
Product QC flow chart
When a quality abnormality is identified during incoming material receipt, inspection, OOS testing, or warehouse storage, the relevant supervisor shall be notified immediately and an abnormality investigation report shall be completed. After review and consolidation of comments from relevant departments, the Food Quality Assurance unit shall establish and manage the case. If necessary, an abnormality meeting shall be convened. The root cause investigation, disposition, and confirmation of preventive measures to avoid recurrence shall be completed within 30 days.
Based on the results of an induced aging experimental model, this product helps postpone aging.
(2018). Safety assessment of the Cistanche tubulosa health food product Memoregain®:Genotoxicity and 28-day repeated dose toxicity test. Food Chem Toxicol Actions. 118:581-588.
(2026). Phenylethanoid Glycosides (AIE2)-Enriched Cistanche tubulosa Extract Attenuates Oxidative Stress and Amyloid Pathology in an Aβ 1−40 - Induced Rat Model of Alzheimer's Disease. Open Access Library Journal. 13(03):14980
(2026).Safety Assessment of Cistanche tubulosa Extract: Genotoxicity and Repeated Dose Toxicity Tests.*Open Access Library Journal. *13(01):1-18
TWI486162B
KR101847501B1
EP2397144B1
JP5968878B2
CA2802441C
AU2011267724B2
